Tevogen Bio (NASDAQ:TVGN) Research Coverage Started at D. Boral Capital
D. Boral Capital began coverage on shares of Tevogen Bio (NASDAQ:TVGN – Free Report) in a research report released on Tuesday, Marketbeat.com reports. The firm issued a buy rating and a $10.00 target price on the stock. Tevogen Bio Price Performance NASDAQ TVGN opened at $1.10 on Tuesday. Tevogen Bio has a one year low […]
More Stories
Florence Pugh: Net Worth, Salary, and Relationship with Finn Cole
British movies, blockbusters, and even Marvel movies have enabled Florence Pugh to have a strong career in Hollywood. She is...
Macron Affirms Support for Greenland Sovereignty Amid US Interest in Annexation
By Rachel Roberts French President Emmanuel Macron has reaffirmed his support for the sovereignty of the Danish territory of Greenland...
DOJ Releases More Epstein Files, Says Some Documents Contain False Claims
By Jack Phillips The Department of Justice (DOJ) on Tuesday morning released thousands of documents related to the now-deceased convicted...
House Oversight Committee Expands Investigation Into Minnesota Fraud
By Jackson Richman The House Oversight Committee expanded its investigation into fraud in Minnesota on Dec. 22. The committee has...
US Economy Expands 4.3 Percent in 3rd Quarter, Topping Expectations
By Andrew Moran Robust consumer spending and a rebound in exports have helped the U.S. economy grow faster than economists...
Is A Man on the Inside Season 3 Confirmed? Everything We Know So Far
Upon the completion of Season 2 of the series A Man on the Inside, people started asking for the series’...